Full year 2025 net revenues of $655 million and fourth quarter net revenues of $174 million Optune Pax approved by the U.S. FDA for the treatment of locally advanced pancreatic cancer, commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results